355 related articles for article (PubMed ID: 24685967)
1. Endothelial dysfunction in metabolic and vascular disorders.
Polovina MM; Potpara TS
Postgrad Med; 2014 Mar; 126(2):38-53. PubMed ID: 24685967
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
Cersosimo E; DeFronzo RA
Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
[TBL] [Abstract][Full Text] [Related]
3. Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management.
Tziomalos K; Athyros VG; Karagiannis A; Mikhailidis DP
Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):140-6. PubMed ID: 19833491
[TBL] [Abstract][Full Text] [Related]
4. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review.
Reddy KJ; Singh M; Bangit JR; Batsell RR
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):633-47. PubMed ID: 20164784
[TBL] [Abstract][Full Text] [Related]
5. Review article: diabetes and atherosclerosis--running on a common road.
Federici M; Lauro R
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():11-5. PubMed ID: 16225464
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance, metabolic syndrome and endothelial dysfunction.
Bigazzi R; Bianchi S
J Nephrol; 2007; 20(1):10-4. PubMed ID: 17347967
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
Dandona P; Ghanim H; Chaudhuri A; Mohanty P
J Diabetes Complications; 2008; 22(1):62-75. PubMed ID: 18191079
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.
Kim JA; Montagnani M; Koh KK; Quon MJ
Circulation; 2006 Apr; 113(15):1888-904. PubMed ID: 16618833
[TBL] [Abstract][Full Text] [Related]
9. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose.
DeFronzo RA; Abdul-Ghani M
Am J Cardiol; 2011 Aug; 108(3 Suppl):3B-24B. PubMed ID: 21802577
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal relationships between insulin resistance and endothelial dysfunction: insights from therapeutic interventions.
Quon MJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):305-12. PubMed ID: 16859113
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
Meyers MR; Gokce N
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
[TBL] [Abstract][Full Text] [Related]
12. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
Cubbon RM; Kahn MB; Wheatcroft SB
Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
[TBL] [Abstract][Full Text] [Related]
13. Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes.
Deedwania PC
Cardiol Clin; 2004 Nov; 22(4):505-9, v. PubMed ID: 15501619
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction.
Han SH; Quon MJ; Koh KK
Curr Opin Lipidol; 2007 Feb; 18(1):58-65. PubMed ID: 17218834
[TBL] [Abstract][Full Text] [Related]
15. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
Kendall DM; Harmel AP
Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788
[TBL] [Abstract][Full Text] [Related]
16. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
Tjokroprawiro A
Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
[TBL] [Abstract][Full Text] [Related]
17. [Vascular dysfunction in metabolic disorders: evaluation of some therapeutic interventions].
Bouskela E; Kraemer de Aguiar LG; Nivoit P; Bahia LR; Villela NR; Bottino DA
Bull Acad Natl Med; 2007 Mar; 191(3):475-92; discussion 492-3. PubMed ID: 18072649
[TBL] [Abstract][Full Text] [Related]
18. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes.
Buscemi S; Re A; Batsis JA; Arnone M; Mattina A; Cerasola G; Verga S
Diabet Med; 2010 Aug; 27(8):872-8. PubMed ID: 20653743
[TBL] [Abstract][Full Text] [Related]
19. The renin angiotensin system as a therapeutic target to prevent diabetes and its complications.
Vijayaraghavan K; Deedwania PC
Cardiol Clin; 2005 May; 23(2):165-83. PubMed ID: 15694745
[TBL] [Abstract][Full Text] [Related]
20. The metabolic syndrome: metabolic changes with vascular consequences.
Wassink AM; Olijhoek JK; Visseren FL
Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
